SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
paramecium
Lv5
920 积分
2022-10-28 加入
最近求助
最近应助
互助留言
Comparison on the effect of seven drugs to prevent relapses of neuromyelitis optica spectrum disorders: A modeling analysis of literature aggregate data
3小时前
已完结
Association of B cell Subsets and Aquaporin-4 antibody titers with Disease Activity in Participants in the N-MOmentum trial Receiving Inebilizumab Treatment (S5.005)
2个月前
已关闭
Immunobiology of neuromyelitis optica spectrum disorders
2个月前
已完结
Efficacy of monoclonal antibodies in neuromyelitis optica: An updated systematic review with meta‐analysis
2个月前
已完结
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
2个月前
已完结
Comparison on the effect of seven drugs to prevent relapses of neuromyelitis optica spectrum disorders: A modeling analysis of literature aggregate data
2个月前
已完结
Infusion-related reactions to rituximab: frequency, mechanisms and predictors
2个月前
已完结
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic review
5个月前
已完结
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
5个月前
已完结
Efficacy and Safety of Monoclonal Antibody Therapy in Neuromyelitis Optica Spectrum Disorders: Evidence from Randomized Controlled Trials
5个月前
已完结
没有进行任何应助
感谢
2个月前
感谢,点赞,速度真快,帮大忙了,么么哒
10个月前
速度真快,帮大忙了,么么哒
10个月前
太感谢了!!!
1年前
谢谢!!
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论